Mariner’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Mariner’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-56,732	Closed	-$23.8K	–	3793
2025 Q4	$23.8K	Sell	56,732 -4,050	-7%	-$2.15K	﹤0.01%	3475
2025 Q3	$40.9K	Hold	60,782	–	–	﹤0.01%	3470
2025 Q2	$32.9K	Buy	+60,782	New	+$36.1K	﹤0.01%	3382
2023 Q4	–	Sell	-16,437	Closed	-$9.86K	–	3165
2023 Q3	$9.86K	Buy	+16,437	New	+$17.6K	﹤0.01%	2871
2023 Q2	–	Sell	-13,716	Closed	-$24K	–	2920
2023 Q1	$24K	Sell	13,716 -1,614	-11%	-$4.61K	﹤0.01%	2716
2022 Q4	$48K	Sell	15,330 -577	-4%	-$2.24K	﹤0.01%	2615
2022 Q3	$78K	Buy	+15,907	New	+$81.7K	﹤0.01%	2254

Other funds holding SGMO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Mariner's SGMO Position: Q1 2026 in Review

Mariner sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 56,732 shares — an estimated $23.8K sold.

Mariner first reported a position in SGMO in Q3 2022 and held it in 7 quarters. The position peaked at $78K in Q3 2022. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

Mariner reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
Mariner sold 56,732 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $23.8K.
Mariner first reported a position in SANGAMO THERAPEUTICS INC in Q3 2022 and held it in 7 quarters.
Mariner's SANGAMO THERAPEUTICS INC position peaked at $78K in Q3 2022.
112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.